Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Outcome of Two Different Targets of Advagraf® Trough Levels Between 4 Months and 12 Months After Transplantation Among de Novo Renal Transplant Recipients.

NCT01744470 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT01744470
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01744470 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Outcome of Two Different Targets of Advagraf® Trough Levels Between 4 Months and 12 Months After Transplantation Among de Novo Renal Transplant Recipients.
Lead sponsor
University Hospital, Tours
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2012
Completion date
March 31, 2015
Enrollment
286 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

de novo transplant disease